Health Care & Life Sciences » Pharmaceuticals | SymBio Pharmaceuticals Ltd.

SymBio Pharmaceuticals Ltd.

SymBio Pharmaceuticals Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY78.19
Market Cap
JPY9.63 B
Shares Outstanding
74.64 M
Public Float
65.41 M

Profile

Address
Toranomon 30 Mori Building
Tokyo Tokyo 105
Japan
Employees -
Website http://www.symbiopharma.com
Updated 09/14/2018
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded on March 25, 2005 by Fuminori Yoshida and is headquartered in Tokyo, Japan.

Financials

View All

Fuminori Yoshida
President, CEO & Representative Director
Kazuo Asakawa
COO, Representative Director & Executive VP